BioBam Bioinformatics
 | |
| Company type | Privately held company |
|---|---|
| Industry | Bioinformatics |
| Founded | 2011 |
| Founder | Stefan Götz, Ana Conesa |
| Headquarters | , |
Area served | Worldwide |
Key people |
|
| Products | |
| Services | |
| Website | https://www.biobam.com |
BioBam is a bioinformatics software company located in Valencia, Spain for creating user-friendly software for the sciences. Its products are used by hundreds of public and private research organizations around the world [1]. The firm was founded in 2011 by Dr. Stefan Götz and Dr. Ana Conesa[2]. The managing director of BioBam is Dr. Stefan Götz.
Products
The firm develops and provides products for the functional annotation and analysis of genomics data sets. The most well-known product is Blast2GO ; the paper describing it [3]which has been cited by over 3528 scientific citations (as of January, 2016). [4] by 2014. Blast2GO is a user-friendly solution for functional genomics specially for non-model organism research [5]. Blast2GO is an all-in-one solution for functional annotation of novel sequences and the genome-wide analysis of annotation data. BioBam counts on important partnerships with leading bioinformatics companies like CLC bio [6] and Biomatters [7], among others [8].
References
- ^ BioBam testimonials (Blast2GO users), list of reference clients and citations
- ^ El Mundo: Innovadores: El "intérprete" mundial del genoma
- ^ Ana Conesa1, Stefan Götz, Juan Miguel García-Gómez, Javier Tero1, Manuel Taló1 and Montserrat Roble2 "Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research " Bioinformatics" Volume 21, Issue 18, p. 3674-3676. doi: 10.1093/bioinformatics/bti610 [1], open access
- ^ Google Scholar Citations(
- ^ Blast2GO Article, Nucleic Acids Res. 2008
- ^ CLC bio and BioBam Deliver Integrated Workflow to Functionally Annotate De Novo Sequenced Genomes and Transcriptomes
- ^ BioBam and Biomatters offer Functional Annotation Tools for Geneious Bioinformatics Platform
- ^ BioBam Partners